These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 22784006)

  • 1. Hereditary angioedema treatment options: the availability of new therapies.
    Aberer W
    Ann Med; 2012 Sep; 44(6):523-9. PubMed ID: 22784006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hereditary angioedema therapies in the United States: movement toward an international treatment consensus.
    Riedl M
    Clin Ther; 2012 Mar; 34(3):623-30. PubMed ID: 22386830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of hereditary angioedema: a review (CME).
    Bhardwaj N; Craig TJ
    Transfusion; 2014 Nov; 54(11):2989-96; quiz 2988. PubMed ID: 24735226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modeling Cost-Effectiveness of On-Demand Treatment for Hereditary Angioedema Attacks.
    Bernstein JA; Tyson C; Relan A; Adams P; Magar R
    J Manag Care Spec Pharm; 2020 Feb; 26(2):203-210. PubMed ID: 31841366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessing the cost and quality-of-life impact of on-demand-only medications for adults with hereditary angioedema.
    Castaldo AJ; Jervelund C; Corcoran D; Boysen HB; Christiansen SC; Zuraw BL
    Allergy Asthma Proc; 2021 Mar; 42(2):108-117. PubMed ID: 33581742
    [No Abstract]   [Full Text] [Related]  

  • 6. Progress in the emergency management of hereditary angioedema: focus on new treatment options in the United States.
    Bernstein JA; Moellman JJ
    Postgrad Med; 2012 May; 124(3):91-100. PubMed ID: 22691903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Icatibant for the treatment of hereditary angioedema.
    Cole SW; Lundquist LM
    Ann Pharmacother; 2013 Jan; 47(1):49-55. PubMed ID: 23249729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence-based recommendations for the therapeutic management of angioedema owing to hereditary C1 inhibitor deficiency: consensus report of an International Working Group.
    Cicardi M; Bork K; Caballero T; Craig T; Li HH; Longhurst H; Reshef A; Zuraw B;
    Allergy; 2012 Feb; 67(2):147-57. PubMed ID: 22126399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Facilitating home-based treatment of hereditary angioedema.
    Bernstein JA; Riedl M; Zacek L; Shapiro RS
    Allergy Asthma Proc; 2015; 36(2):92-9. PubMed ID: 25551795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Update on treatment of hereditary angioedema.
    Buyantseva LV; Sardana N; Craig TJ
    Asian Pac J Allergy Immunol; 2012 Jun; 30(2):89-98. PubMed ID: 22830287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An update on hereditary angioedema.
    Hsu D; Shaker M
    Curr Opin Pediatr; 2012 Oct; 24(5):638-46. PubMed ID: 22935756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hereditary angioedema--treatment].
    Muszyńska A; Fal AM
    Pol Merkur Lekarski; 2008 Jul; 25(145):94-6. PubMed ID: 18839625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hereditary angioedema: management of laryngeal attacks.
    Christiansen SC; Zuraw BL
    Am J Rhinol Allergy; 2011; 25(6):379-82. PubMed ID: 22185739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent advances in management and treatment of hereditary angioedema.
    Sardana N; Craig TJ
    Pediatrics; 2011 Dec; 128(6):1173-80. PubMed ID: 22065270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current status of implementation of self-administration training in various regions of Europe, Canada and the USA in the management of hereditary angioedema.
    Caballero T; Sala-Cunill A; Cancian M; Craig TJ; Neri S; Keith PK; Boccon-Gibod I; Bethune C; Bork K
    Int Arch Allergy Immunol; 2013; 161 Suppl 1():10-6. PubMed ID: 23689239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic management of hereditary angioedema due to C1 inhibitor deficiency.
    Zanichelli A; Mansi M; Periti G; Cicardi M
    Expert Rev Clin Immunol; 2013 May; 9(5):477-88. PubMed ID: 23634741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Summary of the International Multicenter Prospective Angioedema C1-inhibitor Trials 1 and 2 (IMPACT1 and 2).
    Krassilnikova S; Craig ET; Craig TJ
    Expert Rev Clin Immunol; 2010 May; 6(3):327-34. PubMed ID: 20441418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term prophylaxis of hereditary angioedema with androgen derivates: a critical appraisal and potential alternatives.
    Maurer M; Magerl M
    J Dtsch Dermatol Ges; 2011 Feb; 9(2):99-107. PubMed ID: 20946572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Allergy-immunology. New therapies for acute attacks in hereditary angioedema].
    Leimgruber A
    Rev Med Suisse; 2011 Jan; 7(278):103-5. PubMed ID: 21400938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Update on the acute treatment of hereditary angioedema.
    Riedl MA
    Allergy Asthma Proc; 2011; 32(1):11-6. PubMed ID: 21262093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.